Eagle Health Investments LP

Q2 2026 13F-HR Holdings

Location
Greenwich, CT
Holdings as of
6/30/2026
Date filed
8/10/2026
Form type
13F-HR
Num holdings
27
Total value ($000)
$603,308
Net value change ($000)
+31,518 (5.5%)
New positions
6
Sold out positions
5
Turnover %
26.7%
Sector allocation + QoQ delta (equities-only)
Prev filing: 5/15/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q1 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Ascendis Pharma AS 28,314 NEW
CMPS 17,761 155.9%
GH 16,451 57.4%
AXSM 15,923 NEW
IONS 15,428 NEW
ARGX 15,153 27.2%
ICLR 13,856 34.9%
DNTH 12,803 NEW
PTGX 11,538 61.0%
RARE 10,999 59.4%
Top Reduces (Value $000, Stocks/ETFs)
TERN -21,747 -100.0%
NTRA -20,072 -82.4%
BBIO -19,830 -100.0%
ASND -19,819 -100.0%
PRCT -12,100 -100.0%
CNTA -8,512 -100.0%
BSX -2,639 -14.3%
ISRG -278 -13.7%
PCSC -3 -0.7%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type